Showing posts with label Medical writer. Show all posts
Showing posts with label Medical writer. Show all posts

Tuesday, 17 February 2015

Connection between immune system and Immune based therapy or biological therapy



The ultimate cancer immunotherapy agent should be capable to differentiate between cancer and normal cells like specificity, be effective sufficient to kill small or large numbers of tumor cells like sensitivity, and lastly be competent to prevent recurrence of the tumor like durability. Currently, tumor immunology and immune based therapy is one of the most exciting and rapidly growing fields. 

The immune system is generally divided into two primary components such as the innate immune response or system, and the extremely precise but more gradually developing adaptive or acquired immune response or system. Innate immunity is rapidly acting but typically not very specific and includes physicochemical barriers (eg, skin and mucosa), blood proteins such as complement, phagocytic cells (such as neutrophils, macrophages, dendritic cells, and natural killer cells), and cytokines, which synchronize and regulate the cells involved in innate immunity. Adaptive immunity is thought of as the acquired arm of immunity, which allows for exquisite specificity, an ability to remember the previous existence of the pathogen and differentiate self from non-self and, significantly, the ability to respond more vigorously on repeat exposure to the pathogen.
The thought that the immune system may actively prevent the development of neoplasia is termed as cancer immunosurveillance. There are several nonspecific tumor immune based therapy approaches ranging from biological response modifiers (BRM) to recombinant cytokines.
 
www.gapsos.com
Biological response modifiers are molecules that can modify the biological response of cells to changes in its external environment, which in the perspective of cancer immune based therapy, might easily extent specific and non specific immune based therapies.

A number of investigations using recombinant cytokines, growth factors, or hormones in various fashions for human and veterinary cancer patients have been reported up to now. Many have investigated the in vitro and/or in vivo effects of the soluble cytokine (for example interferons, IL 2, IL 12, IL 15 and liposome encapsulation of the cytokine (for example liposomal IL 2) or use a virus, cell, plasmid, liposome DNA complex, or other mechanism to express the cytokine (such as recombinant poxvirus expressing IL 2).

Similar to any type of anticancer treatment, immunotherapy appears to work best in a minimal residual disease setting, signifying its most appropriate use will be in an adjuvant setting with local tumor therapies such as surgery or radiation therapy.

Global Allied Pharmaceuticals (GAP) consist an expert team of oncologists and researchers. To know more information about immunotherapy related services, you can contact on www.gapsos.com.

Monday, 2 February 2015

Uterine cancer patients can be treated with advanced treatment such as immunotherapy.

Uterine cancer is one the leading causes of death related to cancer like disease across the world. The majority of uterine cancer is adenocarcinomas which include serous, mucinous, clear cell, and mixed cell. The epithelial non adenocarcinomas include squamous cell carcinoma, small cell carcinoma, transitional cell carcinoma, and undifferentiated carcinoma. Immunotherapy treatments have various immunotherapeutic cancer agents which are used in all types of this cancer.


www.gapsos.com
www.gapsos.com


Several risk factors are observed that involve age (postmenopausal after the age of 55 years, incidence rate is higher than 95 per 100,000 people in the age of 65 Years), endogenous estrogen exposure ( it causes early menarche, nulliparity, infertility, late menopause, and estrogen producing tumor), exogenous estrogen (Hormonal ReplacementTherapy and drugs such as  Tamoxifen), past medical history (diabetes mellitus, and hypertension), history of endometrial atypical hyperplasia, family history (less than 1% of uterine cancer is due to familial factors), history of breast cancer, and genetic factors (mutations in the MLH1 or MSH2 Gene cause of defect in hereditary nonpolyposis colorectal cancer  have 20% risk to developing endometrial cancer before the age of 50 years, and 60% risk after the age of 60 years)
Various symptoms were observed in the advanced stage of this cancer that involves vaginal bleeding in unexpected postmenopausal women (menorrhagia or metrorrhagia ).Profuse watery discharge is another symptoms.Attention should be paid to the duration and severity of the symptoms.

The significant role play by immunotherapeutic cancer agent in Immunotherapy for  the treatment of uterine cancer that involve monoclonal antibody drug, vaccine based immunotherapy, adoptive T cell therapy. Kinase inhibitors, cytokines, and checkpoint inhibitors. These immunotherapeutic cancer agents have common actions that are increasing the potential of patient’s immune system to fight with specific cancer’s cell. In the present time, no single immunotherapy based drug has received approval by the Food and Drug Administration (FDA) for the treatment of this cancer, but much more are under evaluation via passes through several pre clinical and clinical phases (phase 1, phase 2, and phase 3) for FDA approval.

Bevacizumab is a monoclonal antibody drug  is running in clinical trials (phase 2) under evaluation of safety and efficacy, and for FDA approval. This drug inhibits the growth of specific cancer’s cell via blocking the way of blood flow to the site of cancer. 

Global Allied pharmaceuticals (GAP) have number of immunotherapeutic cancer agents for the treatment of cancer like disease such as uterine. GAP has a responsible team of expert for immunotherapy and antibody drug conjugates.
For more information kindly visit us at www.gapsos.com

Monday, 10 November 2014

Connection between medical writing and drug development process



The guideline essential for a medical writer is to have capacity in remedial terms and thoughts. A post graduate degree in therapeutic science like medication store, health and safety, genetic qualities and regular science can offer a scientific writer with the right kind of learning and shared trait with therapeutic investigation and thoughts. An interchange true essential is ability in forming as a medical writer needs to pass on exploratory data in an adequate and legitimate course to his clients. Look at an allotment of the zone data that a clinical writer should consider:
www.gapsos.com
www.gapsos.com


Learning of Medical Subjects: The inspiration driving a medical writer is to bestow research and remedial data to the client in a way that is legitimate; hence the writer must have escalated data about the distinctive thoughts, wordings and journals used inside that specific field of pharmaceutical. A person who needs to make a restorative report in the subject of nephrology or cardiology can do so without much inconvenience, in case he has experience and data of the field. Of course, most clinical report writers have contrasting medicinal and therapeutic subjects to make on and as it is unfeasible to have cautious adapting in all remedial zones, it is all things considered fitting to at any rate have vital data. As the creator grabs more experience, his understanding on the distinctive subjects will create. 

Learning of Drug Development Process: Often therapeutic piece management need to make clinical investigation reports for recuperating focuses and pharmaceutical associations. Clinical investigation records fuse tradition making, Investigators' Brochures, Clinical Trial reports and drug feasibility and security summaries, which oblige a comprehensive understanding of the pharmaceutical change process, its clinical examination and the different regulations, associated with it. For such reports, a degree in pharmacology can help the Drug Safety Physician to go far.

Learning of Statistics and Inferences: Medical researchers frequently need to oversee quantitative data examination in clinical trials and examination reports, which incorporate point of interest. A medicinal author needs to instigate the results of the actualities in a way that allows masters to easily look at the quality and ampleness of the study blueprint and the persuading makes the investigation yields. An OK methodology to get some understanding of therapeutic realities is to go to workshops and courses controlled by qualified medical journalists for basically this reason.
Visit www.gapsos.com for further information.


Tuesday, 2 September 2014

Medical writer and their work

Medical writing work is the movement of delivering experimental documentation by a specific author. The medicinal essayist normally is not one of the researchers or specialists who performed the exploration. A medical writer, working with specialists, researchers, and other topic masters, makes archives that adequately and obviously depict examination results, item utilize, and other restorative data. The medical writer likewise guarantees that their archives agree to administrative, diary, or different rules regarding substance, configuration, and structure. Medical written work as a capacity got to be built in the pharmaceutical world on the grounds that the business remembered it obliges exceptional ability to create overall organized archives that present data plainly and briefly. A developing number of new medications experience the undeniably unpredictable procedure of clinical trials and administrative methods that prompt business sector approbation. This interest for the reasonable enunciation of restorative science drives an interest for elegantly composed, measures agreeable records that medicinal and science experts can undoubtedly and rapidly read and get it. Correspondingly, restorative foundations participate in translational examination, and some therapeutic scholars have experience offering composition backing to the central agents for stipend applications and specific distributions.
What do they compose? 
www.gapsos.com
 
As a Medical writer you are relied upon to research, read, sort out, decipher and accumulate;
Diary articles, Modified works, blurbs, and slide presentations for logical gatherings, Gift suggestions, Sections for restorative course books, Administrative records about investigator new medication (IND) archives, new medication application (NDA) entries, reports of clinical trials and so on, Materials for lay crowds and patients as magazine, daily paper, web articles, pamphlets, books and other instructive materials. Despite the sort of restorative composition, organizations either dole out it to an in-house writer, or "outsource" it to an agreement medicinal author or medical written work administration.

With this foundation it is clear that not all Medical writers are apparently equivalent. There are two sorts of medicinal scholars; scientific medical writers and marketing medical writers. Scientific medical writers have a progressed medicinal degree and far reaching composition knowledge of exploratory papers for diaries. The undertakings that these authors handle are diary digests, diary articles, doctor talks, restorative instruction materials, administrative reports, web or web content and so forth. Marketing medical writers concentrate on advertising. The employments or undertakings took care of by these essayists are publicizing duplicate, articles, web content, proposal composition, preparing manuals, therapeutic script composing, magazine articles, pamphlets and so forth. Gapsos provides medical writing services to the people worldwide. Our writers are efficient, hardworking and correct.